Low-Dose Cardiac Fluoroscopy System May Be Available By Early 1999
This article was originally published in The Gray Sheet
Cardiac Mariners, Inc. is planning to launch its scanning-beam digital x-ray (SBDX) low-dose fluoroscope early next year, President and CEO Ron Rankin told investors April 27 at the Volpe Brown Whelan & Co. health conference in New York City.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.